Cargando…
The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249448/ https://www.ncbi.nlm.nih.gov/pubmed/34210955 http://dx.doi.org/10.1038/s41408-021-00515-2 |
| _version_ | 1783716907422056448 |
|---|---|
| author | Wudhikarn, Kitsada Bansal, Radhika Khurana, Arushi Hathcock, Matthew A. Bennani, N. Nora Paludo, Jonas Villasboas, Jose C. Wang, Yucai Johnston, Patrick B. Ansell, Stephen M. Lin, Yi |
| author_facet | Wudhikarn, Kitsada Bansal, Radhika Khurana, Arushi Hathcock, Matthew A. Bennani, N. Nora Paludo, Jonas Villasboas, Jose C. Wang, Yucai Johnston, Patrick B. Ansell, Stephen M. Lin, Yi |
| author_sort | Wudhikarn, Kitsada |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8249448 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82494482021-07-20 The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel Wudhikarn, Kitsada Bansal, Radhika Khurana, Arushi Hathcock, Matthew A. Bennani, N. Nora Paludo, Jonas Villasboas, Jose C. Wang, Yucai Johnston, Patrick B. Ansell, Stephen M. Lin, Yi Blood Cancer J Correspondence Nature Publishing Group UK 2021-07-01 /pmc/articles/PMC8249448/ /pubmed/34210955 http://dx.doi.org/10.1038/s41408-021-00515-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Wudhikarn, Kitsada Bansal, Radhika Khurana, Arushi Hathcock, Matthew A. Bennani, N. Nora Paludo, Jonas Villasboas, Jose C. Wang, Yucai Johnston, Patrick B. Ansell, Stephen M. Lin, Yi The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel |
| title | The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel |
| title_full | The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel |
| title_fullStr | The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel |
| title_full_unstemmed | The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel |
| title_short | The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel |
| title_sort | impact of obesity and body weight on the outcome of patients with relapsed/refractory large b-cell lymphoma treated with axicabtagene ciloleucel |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249448/ https://www.ncbi.nlm.nih.gov/pubmed/34210955 http://dx.doi.org/10.1038/s41408-021-00515-2 |
| work_keys_str_mv | AT wudhikarnkitsada theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT bansalradhika theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT khuranaarushi theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT hathcockmatthewa theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT bennaninnora theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT paludojonas theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT villasboasjosec theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT wangyucai theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT johnstonpatrickb theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT ansellstephenm theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT linyi theimpactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT wudhikarnkitsada impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT bansalradhika impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT khuranaarushi impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT hathcockmatthewa impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT bennaninnora impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT paludojonas impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT villasboasjosec impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT wangyucai impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT johnstonpatrickb impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT ansellstephenm impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel AT linyi impactofobesityandbodyweightontheoutcomeofpatientswithrelapsedrefractorylargebcelllymphomatreatedwithaxicabtageneciloleucel |